A compound nano-preparation for treating T-cell acute lymphoblastic leukemia and its preparation method and application

A technology of acute lymphocytes and nano preparations, which is applied in the field of compound nano preparations in the preparation of drugs for the treatment or prevention of T-cell acute lymphoblastic leukemia and the preparation of compound nano preparations, which can solve the problems of increased toxic and side effects of healthy cells and prolong the survival rate , Reasonable formula, easy to use

Active Publication Date: 2021-01-22
XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the cytotoxic effect on malignant T-ALL cells was improved by the combination of IRAK1 / 4 inhibitor and ABT-737, the corresponding toxic side effect on healthy cells was also increased at the same time
However, the systemic side effects caused by chemotherapy drugs are currently the biggest challenge and obstacle in the clinical treatment of leukemia.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A compound nano-preparation for treating T-cell acute lymphoblastic leukemia and its preparation method and application
  • A compound nano-preparation for treating T-cell acute lymphoblastic leukemia and its preparation method and application
  • A compound nano-preparation for treating T-cell acute lymphoblastic leukemia and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] A compound nano-preparation for the treatment of T-cell acute lymphoblastic leukemia, which is made of the following raw materials in parts by weight:

[0038]

[0039] The mixture of the IRAK1 / 4 inhibitor and ABT-737 is prepared by mixing the RAK1 / 4 inhibitor and ABT-737 at a weight ratio of 1:1.

[0040] The mass volume concentration of the polylactic acid-polyglycolic acid is 2.98%.

[0041] The mass volume concentration of the polyvinyl alcohol solution is 2%.

[0042] A method for preparing a compound nano-preparation for the treatment of T-cell acute lymphoblastic leukemia, the steps of which are:

[0043] (1) Dissolve a certain amount of polylactic acid-polyglycolic acid (PLGA) polymer (Evonik Industries, Ltd.), IRAK1 / 4 inhibitor and ABT-737 in 3 mL of acetonitrile solution to obtain a mixed solution;

[0044] (2) The mixed solution that step (1) obtains is emulsified in the polyvinyl alcohol solution of 12mL2% (w / v) to form emulsion, uses the microprobe sonic...

Embodiment 2-6

[0050] A compound nano-preparation for the treatment of T-cell acute lymphoblastic leukemia, which is made of the following raw materials in parts by weight:

[0051] Example 2 Example 3 Example 4 Example 5 Example 6 Mixture of RAK1 / 4 inhibitors and ABT-737 1.5 2.5 3.5 4.5 5.5 polylactic acid-polyglycolic acid 52 70 80 100 40 Acetonitrile solution 1 2 3 4 5 polyvinyl alcohol solution 12 24 24 45 45

[0052] Its preparation steps are identical with embodiment 1.

[0053] Characterization analysis:

[0054] Dynamic light scattering (DLS) analyzes the IRAK / ABT-NP that embodiment 1-6 step (4) obtains, and the result shows, the average diameter of IRAK / ABT-NP is 100nm, monodisperse size distribution; By SEM and TEM studied surface morphology, indicating that the particles are spherical (see figure 1 ).

[0055] The IRAK / ABT-NP in vitro release test that embodiment 1 step (4) obtains:

[0056] In vitro release of IR...

Embodiment 7

[0067] An application of a compound nano-preparation in the preparation of a medicine for treating or preventing T-cell acute lymphoblastic leukemia, the steps of which are:

[0068] A, the dry compound nano powder preparation is dispersed in saline for injection, the concentration is 2mg / mL;

[0069] B. Vibrate on a vortex to make the nanosuspension fully mixed, and then intravenously inject or drip.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses a compound nano-preparation for treating T-cell acute lymphoblastic leukemia and its preparation method and application. Alcohol composition. The steps are: (1) dissolving polylactic acid-polyglycolic acid polymer, IRAK1 / 4 inhibitor and ABT-737 in acetonitrile solution to obtain a mixed solution; (2) emulsifying the mixed solution in polyvinyl alcohol solution to form The emulsion was emulsified on an ice bath using a micro-probe sonicator to obtain an emulsion; (3) the emulsion was stirred at room temperature to obtain inhibitors and compound nanoparticles; (4) the compound nanoparticles were ultracentrifuged in an ultracentrifuge and used Washed with distilled water, freeze-dried and stored to obtain inhibitors and nanoparticles. It also relates to the application of compound nano preparations. The formula is reasonable, the use is convenient, and the metabolism time of the drug is prolonged; the absorption of the drug in tumor cells is increased, thereby further enhancing the synergistic effect of the drug.

Description

technical field [0001] The invention belongs to the technical field of compound nano preparations, in particular to a compound nano preparation drug for treating T-cell acute lymphoblastic leukemia, and also relates to a preparation method of a compound nano preparation for treating T-cell acute lymphoblastic leukemia, and also relates to The invention relates to the use of a compound nano-preparation in the preparation of medicines for treating or preventing T-cell acute lymphoblastic leukemia. Background technique [0002] T-cell acute lymphoblastic leukemia (T-ALL) is caused by the clonal expansion of mutant T-cell progenitor cells and is considered a high-risk leukemia, accounting for about 15% of acute lymphoblastic leukemia in children and up to 25% in adults. With contemporary chemotherapy, complete remission rates are as high as 85% in children, but not ideal in adults. Only 15%-25% of adult T-ALL patients have a good prognosis after relapse, and the 5-year survival...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/51A61K47/34A61K47/32A61K45/06A61K31/635A61P35/02
Inventor 吴小艳
Owner XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap